General Information of Drug-Metabolizing Enzyme (DME ID: DME0539)
DME Name Nicotinate-nucleotide adenylyltransferase 2 (NMNAT2), Homo sapiens DME Info
UniProt ID
NMNA2_HUMAN
EC Number    EC: 2.7.7.1     (Click to Show/Hide the Complete EC Tree)
Transferase
Kinase
Nucleotidyltransferase
EC: 2.7.7.1
Lineage    Species: Homo sapiens     (Click to Show/Hide the Complete Species Lineage)
Kingdom: Metazoa
Phylum: Chordata
Class: Mammalia
Order: Primates
Family: Hominidae
Genus: Homo
Species: Homo sapiens
Interactome
Disease Specific Interactions between Host Protein and DME (HOSPPI)
      ICD Disease Classification 02 Neoplasms
               ICD-11: 2B30 Lymphoma Click to Show/Hide the Full List of HOSPPI:        1 HOSPPI
                     DNA methylation
                            DNA methyltransferase (DNMT) Lymphoma Moderate hypomethylation
Interaction Name DNMT-NMNAT2 interaction
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue Moderate hypomethylation
p-value: 1.75E-09; delta-beta: -2.68E-01
Description DNA methyltransferase (DNMT) is reported to moderatly hypo-methylate the NMNAT2 gene, which leads to a moderatly increased expression of the drug-metabolizing enzyme Nicotinate-nucleotide adenylyltransferase 2. As a result, the interaction between DNMT and NMNAT2 can moderatly affect the drug-metabolizing process of Nicotinate-nucleotide adenylyltransferase 2.
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Methylation Level Click to View the Clearer Original Diagram
               ICD-11: 2C30 Melanoma Click to Show/Hide the Full List of HOSPPI:        1 HOSPPI
                     Histone modification
                            Histone deacetylases (HDACs) Melanoma Repression
Uniprot ID
HDAC1_HUMAN
Interaction Name HDACs-NMNAT2 interaction [1]
Studied Cell Lines SK-MEL-3 cell line
Description Histone deacetylases (HDACs) are reported to deacetylate the NMNAT2 gene and thereby repress the transcriptional activity of the drug-metabolizing enzyme Nicotinate-nucleotide adenylyltransferase 2. As a result, the interaction between HDACs and NMNAT2 can inhibit the drug-metabolizing process of Nicotinate-nucleotide adenylyltransferase 2.
References
1 Whole-transcriptomic Profile of SK-MEL-3 Melanoma Cells Treated with the Histone Deacetylase Inhibitor: Trichostatin A. Cancer Genomics Proteomics. Sep-Oct 2018;15(5):349-364.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.